ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 675,62
-0,26%
Dow Jones
39 375,87
0,17%
DAX
18 475,45
0,12%
Brent Oil
86,775
-0,64%
Bitcoin
56 610,40
-0,65%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Telesis Bio Inc (TBIO)

  7. Telesis Bio Inc (TBIO) Actualités

TBIO

Telesis Bio (TBIO)

Telesis Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TBIO
DateHeureSourceTitreSymboleSociété
12/06/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/06/202402h40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
10/05/202412h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
09/05/202422h05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/05/202422h05GlobeNewswire Inc.Telesis Bio Announces Reverse Stock SplitNASDAQ:TBIOTelesis Bio Inc
18/04/202415h00GlobeNewswire Inc.Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadershipNASDAQ:TBIOTelesis Bio Inc
28/03/202421h05GlobeNewswire Inc.Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/03/202400h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
26/02/202415h15GlobeNewswire Inc.Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
13/11/202322h22GlobeNewswire Inc.Telesis Bio Reports Third Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
07/11/202315h00GlobeNewswire Inc.Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023NASDAQ:TBIOTelesis Bio Inc
03/11/202317h00GlobeNewswire Inc.Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNANASDAQ:TBIOTelesis Bio Inc
28/09/202321h48GlobeNewswire Inc.Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGSNASDAQ:TBIOTelesis Bio Inc
29/08/202322h05GlobeNewswire Inc.Telesis Bio Appoints William J. Kullback Chief Financial OfficerNASDAQ:TBIOTelesis Bio Inc
10/08/202322h05GlobeNewswire Inc.Telesis Bio Reports Second Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
04/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TBIOTelesis Bio Inc
03/08/202323h00GlobeNewswire Inc.Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023NASDAQ:TBIOTelesis Bio Inc
27/07/202323h28Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TBIOTelesis Bio Inc
08/06/202315h05GlobeNewswire Inc.Telesis Bio to Present at Jefferies Healthcare Conference 2023NASDAQ:TBIOTelesis Bio Inc
06/06/202309h00GlobeNewswire Inc.Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023NASDAQ:TBIOTelesis Bio Inc
05/06/202323h30GlobeNewswire Inc.Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common StockNASDAQ:TBIOTelesis Bio Inc
31/05/202323h29GlobeNewswire Inc.Telesis Bio Secures Financing of $28.0 MillionNASDAQ:TBIOTelesis Bio Inc
23/05/202315h00GlobeNewswire Inc.Telesis Bio to Present at SynBioBeta 2023NASDAQ:TBIOTelesis Bio Inc
22/05/202318h00GlobeNewswire Inc.Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning KitNASDAQ:TBIOTelesis Bio Inc
18/05/202316h00GlobeNewswire Inc.Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep KitNASDAQ:TBIOTelesis Bio Inc
15/05/202315h00GlobeNewswire Inc.Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)NASDAQ:TBIOTelesis Bio Inc
11/05/202322h05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
27/04/202322h05GlobeNewswire Inc.Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023NASDAQ:TBIOTelesis Bio Inc
31/03/202315h00GlobeNewswire Inc.Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-upNASDAQ:TBIOTelesis Bio Inc
22/03/202311h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TBIOTelesis Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TBIO

Dernières Valeurs Consultées

BIT
P215C5
NLBNPIT215C5 20241220 70
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés